Arrowhead Pharmaceuticals
ARWR
#2206
Rank
ยฃ6.59 B
Marketcap
ยฃ46.80
Share price
0.43%
Change (1 day)
67.49%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -ยฃ0.13 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ0.66 Billion. In 2025 the company made an earning of ยฃ0.26 Billion, an increase over its 2024 earnings that were of -ยฃ0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ0.13 Billion-146.54%
2025 ยฃ0.26 B-157.5%
2024 -ยฃ0.46 Billion112.45%
2023 -ยฃ0.22 Billion87.79%
2022 -ยฃ0.12 Billion-20.1%
2021 -ยฃ0.15 Billion67.59%
2020 -ยฃ85.09 Million-347.53%
2019 ยฃ34.37 M-245.59%
2018 -ยฃ23.61 Million-13.17%
2017 -ยฃ27.2 Million-52.28%
2016 -ยฃ56.99 Million-16.57%
2015 -ยฃ68.3 Million30.32%
2014 -ยฃ52.41 Million171.62%
2013 -ยฃ19.3 Million16.56%
2012 -ยฃ16.56 Million107.53%
2011 -ยฃ7.98 Million
2008 -ยฃ28.1 Million-8.07%
2007 -ยฃ30.57 Million70.37%
2006 -ยฃ17.94 Million122.51%
2005 -ยฃ8.07 Million147.41%
2004 -ยฃ3.26 Million2002.28%
2003 -ยฃ0.16 Million-85.61%
2002 -ยฃ1.08 Million1371.97%
2001 -ยฃ0.08 Million-13.45%
2000 -ยฃ0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.84 B-16,534.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-ยฃ2.31 Billion 1,809.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 B-253.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ89.09 Million-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.85 B-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-ยฃ62.33 Million-48.39%๐Ÿ‡บ๐Ÿ‡ธ USA